全文获取类型
收费全文 | 5446篇 |
免费 | 658篇 |
国内免费 | 3篇 |
出版年
2022年 | 40篇 |
2021年 | 91篇 |
2020年 | 49篇 |
2019年 | 62篇 |
2018年 | 79篇 |
2017年 | 75篇 |
2016年 | 118篇 |
2015年 | 182篇 |
2014年 | 193篇 |
2013年 | 265篇 |
2012年 | 279篇 |
2011年 | 297篇 |
2010年 | 168篇 |
2009年 | 153篇 |
2008年 | 216篇 |
2007年 | 217篇 |
2006年 | 181篇 |
2005年 | 203篇 |
2004年 | 187篇 |
2003年 | 190篇 |
2002年 | 222篇 |
2001年 | 165篇 |
2000年 | 163篇 |
1999年 | 134篇 |
1998年 | 97篇 |
1997年 | 90篇 |
1996年 | 69篇 |
1995年 | 66篇 |
1994年 | 57篇 |
1993年 | 58篇 |
1992年 | 105篇 |
1991年 | 109篇 |
1990年 | 87篇 |
1989年 | 80篇 |
1988年 | 68篇 |
1987年 | 84篇 |
1986年 | 55篇 |
1985年 | 64篇 |
1984年 | 51篇 |
1983年 | 45篇 |
1982年 | 44篇 |
1981年 | 51篇 |
1980年 | 50篇 |
1979年 | 50篇 |
1978年 | 56篇 |
1977年 | 48篇 |
1976年 | 39篇 |
1975年 | 53篇 |
1974年 | 48篇 |
1973年 | 44篇 |
排序方式: 共有6107条查询结果,搜索用时 31 毫秒
11.
12.
Isolation and composition of a photosynthetic reaction center complex from Rhodopseudomonas spheroides 总被引:6,自引:0,他引:6
D W Reed 《The Journal of biological chemistry》1969,244(18):4936-4941
13.
14.
Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. 总被引:6,自引:0,他引:6
C Hilbich B Kisters-Woike J Reed C L Masters K Beyreuther 《Journal of molecular biology》1992,228(2):460-473
The deposition of amyloid protein aggregates in brain is the main pathological feature of Alzheimer's disease. Their principal constituent is a peptide termed beta A4, which comprises up to 43 amino acid residues. It is highly insoluble under physiological conditions and aggregates into filaments that form very dense clusters in vivo and in vitro. Based on a beta A4 prototype sequence spanning residues 10 to 42 or 43, we have designed analogues in which hydrophobic amino acid residues in position 17 to 20 were substituted by more hydrophilic residues. Depending on the kind of newly introduced amino acids and their position within the sequence, the substitution of only two residues led to variants exhibiting a broad spectrum of different properties. Common to them was a reduced beta-sheet content after solubilization in water and in the solid state. Some of the variants showed significantly reduced amyloidogenicity: although still forming filaments, they did not aggregate into the highly condensed depositions that are typical for amyloid. In addition, they could be solubilized in 200 mM-NaCl and KCl. When mixed with beta A4 peptides bearing the natural sequence, two of the analogues could inhibit the formation of filaments in vitro. These results demonstrate that a well-preserved hydrophobic core around residues 17 to 20 of beta A4 is crucial for the formation of beta-sheet structure and the amyloid properties of beta A4. The introduction of structural alterations within this region may guide the development of reagents for the therapy of Alzheimer's disease. 相似文献
15.
16.
17.
Davide Danovi Amos Folarin Sabine Gogolok Christine Ender Ahmed M. O. Elbatsh P?r G. Engstr?m Stefan H. Stricker Sladjana Gagrica Ana Georgian Ding Yu Kin Pong U Kevin J. Harvey Patrizia Ferretti Patrick J. Paddison Jane E. Preston N. Joan Abbott Paul Bertone Austin Smith Steven M. Pollard 《PloS one》2013,8(10)
Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults and there are few effective treatments. GBMs contain cells with molecular and cellular characteristics of neural stem cells that drive tumour growth. Here we compare responses of human glioblastoma-derived neural stem (GNS) cells and genetically normal neural stem (NS) cells to a panel of 160 small molecule kinase inhibitors. We used live-cell imaging and high content image analysis tools and identified JNJ-10198409 (J101) as an agent that induces mitotic arrest at prometaphase in GNS cells but not NS cells. Antibody microarrays and kinase profiling suggested that J101 responses are triggered by suppression of the active phosphorylated form of polo-like kinase 1 (Plk1) (phospho T210), with resultant spindle defects and arrest at prometaphase. We found that potent and specific Plk1 inhibitors already in clinical development (BI 2536, BI 6727 and GSK 461364) phenocopied J101 and were selective against GNS cells. Using a porcine brain endothelial cell blood-brain barrier model we also observed that these compounds exhibited greater blood-brain barrier permeability in vitro than J101. Our analysis of mouse mutant NS cells (INK4a/ARF−/−, or p53−/−), as well as the acute genetic deletion of p53 from a conditional p53 floxed NS cell line, suggests that the sensitivity of GNS cells to BI 2536 or J101 may be explained by the lack of a p53-mediated compensatory pathway. Together these data indicate that GBM stem cells are acutely susceptible to proliferative disruption by Plk1 inhibitors and that such agents may have immediate therapeutic value. 相似文献
18.
19.
20.